Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsTrendsHealth

IMF chief Kristalina Georgieva tests positive for COVID-19

"IMF Managing Director Kristalina Georgieva has tested positive for COVID-19. She is experiencing mild symptoms and is working remotely while isolating at home," the Washington-based crisis lender's spokesman Gerry Rice said in a statement.

April 29, 2022 / 07:17 AM IST
Source: Reuters

Source: Reuters

IMF Managing Director Kristalina Georgieva has tested positive for COVID-19, a spokesman said Thursday, stressing she had only "mild symptoms."

"IMF Managing Director Kristalina Georgieva has tested positive for COVID-19. She is experiencing mild symptoms and is working remotely while isolating at home," the Washington-based crisis lender's spokesman Gerry Rice said in a statement.

"She is fully vaccinated and boosted," he added.

Georgieva joins the ranks of Washington elites who have tested positive lately amid a new rise in daily coronavirus infections.

This group includes multiple members of Congress and Vice President Kamala Harris, who tested positive on Tuesday.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
At the time, she said she was not considered to have been in close contact with President Joe Biden.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

AFP
first published: Apr 29, 2022 07:17 am
Sections
ISO 27001 - BSI Assurance Mark